Author Archives: Gilman Law

Standard Microsystems Breach of Fiduciary Duty Lawsuit Over Microchip Technology Acquisition

Microchip Technology Acquisition of Standard Microsystems Prompts Breach of Fiduciary Investigation. Standard Microsystems Investors Call (888) 252-0048 For A Free Review.

Free Consultation and Case Review to Standard Microsystems Shareholders

About the Standard Microsystems Breach of Fiduciary Duty Investigation

Standard Microsystems Acquisition Lawsuit for Breach of Fiduciary Duty

Standard Microsystems Acquisition Lawsuit for Breach of Fiduciary Duty

The Investment Losses and Securities Fraud Law Firm of Gilman Law LLP is investigating potential breach of fiduciary duty claims by current shareholders of Standard Microsystems Corporation (“Standard Microsystems”) (NASDAQ: SMSC) against the board of directors of the Company in connection with their efforts to sell the Standard Microsystems Corp. to Microchip Technology Incorporated (NASDAQ: MCHP), in an all-cash deal valued at about $939 million.

Standard Microsystems Corporation and Microchip Technology Incorporated are allegedly discussing terms under a proposed transaction that will offer Standard Microsystems’ stockholders $37.00 in cash for each share of Standard Microsystems’ common stock. Our Breach of Fiduciary Duty Investigation concerns whether Standard Microsystems’ Board of Directors breached fiduciary duties by failing to conduct an adequate and fair sales process prior to entering into to this proposed transaction. The Standard Microsystems Lawsuit Investigation further investigates whether the proposed transaction undervalues Standard Microsystems’ shares and by how much this proposed transaction undervalues the Company to the detriment of Standard Microsystems’ shareholders.

Legal Help for Standard Microsystems Shareholders

If you are a current shareholder of Standard Microsystems and would like to learn more about the Standard Microsystems Breach of Fiduciary Duty Investigation, you may complete our Free Consultation and Case Review for Online or call our investment fraud attorneys TOLL FREE at (888) 252-0048. Our securities fraud lawyers have over 35 years of experience litigating securities and other types of class action cases and have been involved in all major aspects of securities litigation. The investment fraud attorneys at Gilman Law LLP focus on cases involving stock manipulation, securities fraud, investments fraud, shareholder rights violations, and securities arbitration.

Free Consultation and Case Review to Standard Microsystems Shareholders

 

First Solar Securities Fraud Lawsuit (NASDAQ: FSLR)

National securities law firm Gilman Law LLP announces that a First Solar Securities Fraud Lawsuit was commenced in the US District Court, District of Arizona on behalf of purchasers of First Solar securities (NASDAQ: FSLR).  The lawsuit alleges that First Solar and certain of its officers and directors issued materially false and misleading statements to investors, thereby violating the Securities Exchange Act of 1940.

Those who purchased or otherwise acquired shares of First Solar securities between April 40, 2008 and February 28, 2012 (the “class period”), and incurred losses in excess of $50,000 should contact the Securities Law Firm Gilman Law LLP before the May 14, 2012 Deadline.  Investors may contact Kenneth Gilman, the managing partner of Gilman Law LLP, at (888) 252-0048 or by completing the online form below for a Free Evaluation of your case.

First Solar Securities Fraud Lawsuit Details

Based in Tempe, Arizona, First Solar designs and manufacturers solar modules.  The Company uses a thin film semiconductor technology to manufacture electricity-producing solar modules.  The First Solar securities fraud lawsuit alleges that throughout the Class Period, First Solar failed to disclose certain manufacturing flaws which impacted the Company’s earnings.  The suit further alleges that the Company improperly recognized revenue concerning certain products in its systems business and lacked adequate internal and financial controls.  As a result, First Solar lacked a reasonable basis for their positive statements about the Company, its operations and earnings during the Class Period.  Once First Solar began to disclose the truth on February 29, 2012, the price of First Solar securities declined $4.10 per share or 11%, to close at $40.40 per share.

ViroPharma, Inc. Class Action Securities Lawsuit Prompted By Unfair Competition

Investors with substantial losses from investments in ViroPharma, Inc. (VPHM) as a result of ViroPharma’s unfair methods of competition are encouraged to contact the Leading Investment Losses Law Firm of Gilman Law LLP to discuss your rights.

The Leading Investment Losses and Stock Fraud Law Firm of Gilman Law LLP is investigating potential claims on behalf of purchasers of ViroPharma Inc. (“ViroPharma” or the “Company”) (NASDAQ:VPHM) common stock concerning possible violations of federal securities laws.

Information about the ViroPharma Class Action Securities Lawsuit

ViroPharma Class Action Securities Lawsuit

ViroPharma Class Action Securities Lawsuit

The Federal Trade Commission is currently investigating whether ViroPharma engaged in unfair methods of competition in relation to its antibiotic Vancocin. Furthermore, the Food and Drug Administration recently denied ViroPharma’s petition to maintain market exclusivity. By April 11, 2012, four companies began selling authorized generic versions of Vancocin. Since announcing the investigation by the Federal Trade Commission, shares of ViroPharma have fallen over 21 percent.

If you own or otherwise acquired ViroPharma stock and wish to obtain additional information about the investigation and your legal rights, please contact our experienced securities attorneys via email at consultations@gilmanlawllp.com, by telephone toll free at (888) 252-0048, or by completing the free online legal consultation form to the left of this page.

About Gilman Law LLP

The experienced Investment Losses and Securities Law Attorneys at Gilman Law LLP have over 35 years of experience in complex securities litigation involving securities fraud, derivative claims, and other shareholder lawsuits. The securities attorneys at Gilman Law LLP have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major securities lawsuits and have successfully recovered hundreds of millions of dollars on behalf of investors.

ZELTIQ Aesthetics Securities Fraud Lawsuit (NASDAQ: ZLTQ)

National securities law firm Gilman Law LLP announces that a ZELTIQ Aesthetics class action securities fraud lawsuit has been commenced against ZELTIQ Aesthetics, Inc. (“ZELTIQ”) (NASDAQ: ZLTQ) and certain of its officers and directors in Superior Court of the State of California for the County of Alameda.

The ZELTIQ Aesthetics securities fraud lawsuit alleges that ZELTIQ violated Federal securities laws by issuing false and misleading information or omissions in the Company’s Registration Statement and Prospectus, issued in connection with the Offering that was completed on October 24, 2011.

If you purchased or otherwise acquired shares of ZELTIQ pursuant to and/or traceable to the Company’s initial public offer (the “IPO” or “Offering”) in October 2011, you should contact Gilman Law LLP to discuss your rights as to recovery of your losses or for additional information.  For a free evaluation of your case, please complete the online form or CALL TOLL FREE (888) 252-0048.

Based in Pleasanton, California, ZELTIQ is a medical technology company that engages in developing and commercializing non-invasive products for the selective reduction of fat.  ZELTIQ went public in October 2011, which raised $89.3 million, at $13.00 per share.  The complaint alleges that ZELTIQ’s Registration Statement failed to disclose, among other things, that the Company was going to initiate a transition to a direct sales force in certain key international markets in the 2011 fiscal fourth quarter, which would negatively impact the Company’s near term financial performance.  The suit further alleges that the Company’s business during the fiscal fourth quarter was subject to seasonal trends that negatively impacted its financial performance.

Once ZELTIQ issued a press release on March 6, 2012 announcing fourth quarter 2011 sales and profits well below analyst estimates, shares of ZELTIQ declined $3.75 per share, or 33.75%, to close at $7.36 per share, on unusually heavy trading volume.  The closing price represented a cumulative loss of $5.64, or 43.38%, of the value of Company’s shares at the IPO price of $13.00 per share.

O’Charley’s Lawsuit Investigation Over Acquisition By Fidelity National Financial

O’Charley’s Lawsuit Investigation | Breaches of Fiduciary Duties | Self Dealing | Violations in Acquisition | Fidelity National Financial Acquisition

Gilman Law LLP, a national securities law firm, announces a class action lawsuit investigation on behalf of O’Charley’s common stock shareholders. The O’Charley’s investigation concerns possible breaches of fiduciary duty and other violations of the law by directors and/or officers of O’Charley’s, Inc., related to the sale of the company to Fidelity National Financial, Inc.

If you own shares of stock in O’Charley’s, Inc. and would like more information concerning your rights and potential remedies, please contact Gilman Law LLP at (239) 221-8401 or submit the free consultation form to speak with a securities attorney at Gilman Law LLP. O’Charley’s common stock shareholders may be able to file a class action lawsuit to preserve their right to vote on the details of the transaction.

O’Charley’s Acquisution Details

The investigation concerns the terms of the O’Charley’s acquisition with Fidelity. Specifically, the terms of the deal indicate that shareholders will receive $9.85 in cash for each share of O’Charley’s common stock. Fidelity National Financial currently owns over 2 million, or approximately 9.5%, of all outstanding shares of O’Charley’s common stock. Further, Fidelity announced that it plans to commence a tender offer for the remaining shares on or about February 24, 2012.

Gilman Law LLP is focused on whether the directors and officers of O’Charley’s are undertaking a fair process to obtain maximum value and adequately compensate the common stock shareholders. Analysts polled by Bloomberg had only expected O’Charley’s revenue of $181 million for quarterly revenue, when the company actually reported revenue of $182.16 million.

The terms of the deal also provide that O’Charley’s officers and directors will remain employed by the surviving corporation. Gilman Law LLP is investigating whether the directors and officers engaged in any type of self-dealing or other employment guarantees when making the decisions to enter into the deal.

Gilman Law Firm History

Gilman Law Securities Law Firm Logo

Helping Victims of Investment Fraud for Over 40 Years

The securities attorneys at Gilman Law have over 35 years of experience litigating securities cases as well as other types of class action cases, and have been involved in all major aspects of securities litigation. Our securities lawyers focus their practice on cases involving stock manipulation, securities fraud, investments fraud, shareholder rights violations, and securities arbitration. For a free evaluation of your case, please contact our national securities lawyers TOLL FREE at (239) 221-8401.

Illumina Class Action Lawsuit Alleging Conflict of Interest in Proposed Acquisition by Roche

Illumina Class Action Lawsuit Announced by Gilman Law LLP on Behalf of Shareholders Alleging Conflict of Interest in Recent Proposed Acquisition by Roche

Illumina Class Action Lawsuit was filed by shareholders in Illumina, Inc.(NASDAQ:ILMN) alleging conflicts of interest in the recent proposed acquisition by Roche. The plaintiffs allege that the defendants breached their fiduciary duties by, among other things, by refusing to engage in negotiations and/or substantive dialogue with Roche which resulted in the defendants failing to get the best price for Illumina shareholders.

Those investors who purchased or otherwise acquired Illumina, Inc. shares and currently hold those shares should complete the free consultation. Investors may contact Gilman Law LLP by phone at (239) 221-8401, by email at kgilman@gilmanpastor.com, or by completing the free consultation form below.

To join in the Illumina Class Action Lawsuit, click here for a free consultation.

Illumina Class Action Lawsuit Details

During December 2011, Roche communicated to top executives at Illumina, that Roche had an interest in acquiring Illumina. Plaintiffs claim that shortly thereafter Roche formally offered to acquire all of the shares of Illumina’s common stock. Instead of considering this offer or negotiating a higher bid, Defendants, at the advice of Goldman Sachs, flatly rejected the offer. Goldman Sachs benefited financial from its recommendation that Illumina reject the Roche offer.

On January 24, 2012, Roche publicly announced that it wanted to acquire all outstanding shares of Illumina, Inc. for $44.50 per share. Following the announcement Illumina shares surged on January 25, 2012 above the current offer and closed as high as $55.15.

Again, instead of negotiating a higher price Illumina announced on January 26, 2012 that its Board of Directors adopted a “Rights Agreement,” a/k/a poison pill, which allows directors to deflect offers for a company. Plaintiffs claim that defendants failed to act in the best interest of shareholders and failed to maximize the value shareholders would receive by depriving the Illumina, Inc. public stockholders of the opportunity to fully realize the benefits of their investment.

About Gilman Law LLP

The securities law attorneys of Gilman Law have more than 35 years of experience in securities law and have been involved in all major aspects of securities litigation. Gilman Law handles cases involving stock manipulation, securities fraud, investments fraud, shareholder rights violations, and securities arbitration.

Great Wolf Breach of Fiduciary Duty Investigation Concerning Buyout of Great Wolf Resorts by Apollo Global Management

Investigation into Breach of Fiduciary Duty Claims concerning the Acquisition of Great Wolf Resorts by Apollo Global Management by Leading National Securities Law Firm Gilman Law LLP

The National Securities Law Firm Gilman Law LLP is investigating potential breach of fiduciary duty claims by current shareholders of Great Wolf Resorts, Inc. (“Great Wolf”) (NASDAQ: WOLF) against the board of directors of Great Wolf in connection with their efforts to sell the Company to Apollo Global Management, LLC (NYSE: APO), a leading global asset manager.

On March 13, 2012, Great Wolf announced that it had entered into a definitive merger agreement to be acquired by Apollo.  According to the terms of the deal, Apollo will purchase all outstanding shares of Great Wolf common stock for $5.00 per share.  However, one leading market analyst released a target price of Great Wolf shares at $6.00 per share.  Gilman Law is investigating whether Great Wolf shareholders are receiving adequate compensation for their shares in the buyout, whether the transaction undervalues Great Wolf stock, and whether Great Wolf’s board attempted to obtain the highest share price for all shareholders prior to agreeing to the deal.

If you are a current shareholder of Great Wolf and would like to learn more about the breach of fiduciary duty investigation by the National Securities Law Firm Gilman Law LLP, you may contact our office for a free consultation by calling (239) 221-8401 or by completing the free consultation form online.

About the National Securities Law Firm Gilman Law LLP

The leading national securities law attorneys at Gilman Law have over 35 years of experience litigating securities and other class action cases. Our firm has been involved in all major aspects of securities litigation, including cases involving stock manipulation, securities fraud, investment fraud, and shareholder rights violations, as well as securities class action suits on behalf of both individual and institutional investors.

Health Management Shareholders Advised of Upcoming Deadline of March 26, 2012 Concerning Alleged Securities Fraud Violations

Gilman Law LLP, a leading national securities fraud law firm located in Naples, Florida, announces a securities fraud class action lawsuit has been filed on behalf of purchasers of the common stock of Health Management Associates, Inc. (“Health Management” or the “Company”) concerning whether the company and certain of its officers and directors have violated federal securities laws.  Click here to view the press release.

If you purchased or otherwise acquired the common stock of Health Management Associates, Inc. during the period between July 27, 2009 and January 9, 2012 (the “Class Period”) and either lost money on the transaction or still hold the shares, you should contact Securities Fraud Law Firm of Gilman Law LLP by March 26, 2012 to discuss your rights, including as to recovery of your losses or to obtain additional information.

For a free evaluation of your Health Management Securities Fraud case, please contact Gilman Law TOLL FREE at (888) 252-0048.

Taleo Shareholder Lawsuit Alleging Breaches of Fiduciary Duties in Oracle Acquisition

Taleo Class Action Lawsuit Filed on Behalf of Investors in Taleo Corporation Alleging Breaches of Fiduciary Duty by the Taleo Board in Connection with Acquisition of Taleo by Oracle Corporation

Taleo Class Action Lawsuit was filed by Investors in Taleo Corporation (NASDAQ:TLEO) alleging breaches of fiduciary and violations of other state law against the Taleo Board in connection with the sale of the company to Oracle Corporation. Specifically, the complaint concerns whether the Taleo Board of Directors breached their fiduciary duties to Taleo stockholders by failing to adequately shop the Company before entering into this transaction and whether Oracle Corporation is underpaying for Taleo shares, thus unlawfully harming Taleo stockholders. Furthermore, at least one analyst set a price target 13% higher than the price offered per Taleo share.

Those investors who purchased or otherwise acquired Taleo Corporation shares and currently hold those shares should complete the free consultation. Investors may contact Gilman Law LLP by phone at (239) 221-8401, by email at kgilman@gilmanpastor.com, or by completing the free consultation form below.

To join in the Taleo Corporation Class Action Lawsuit, click here for a free consultation.

About Gilman Law LLP

The securities law attorneys of Gilman Law have more than 35 years of experience in securities law and have been involved in all major aspects of securities litigation. Gilman Law handles cases involving stock manipulation, securities fraud, investments fraud, shareholder rights violations, and securities arbitration.

AboveNet Acquisition Breach of Fiduciary Duty Investigation (NYSE: ABVT)

Gilman Law LLP announces an investigation into a possible breach of fiduciary duty by the AboveNet, Inc. board of directors concerning the acquisition by Zayo Group, LLC.  Current shareholders of AboveNet, Inc. are encouraged to contact our office for a free consultation at (888) 252-0048.

The National Securities Law Firm Gilman Law LLP is investigating potential breach of fiduciary duty claims concerning current shareholders of AboveNet, Inc. (“AboveNet”) (NYSE: ABVT) and other violations of state law by the board of directors of AboveNet in connection with the proposed acquisition of AboveNet by the privately-held Zayo Group, LLC. This breach of fiduciary duty investigation seeks to determine whether the board breached its fiduciary duties by failing to maximize shareholder value in negotiating the proposed going-private transaction. The definitive acquisition agreement involves an all cash transaction with a total equity value of approximately $2.2 billion.

Under the terms of the agreement, AboveNet shareholders will receive $84.00 in cash for each share they own.  Shareholder’s investigation is focused on whether AboveNet shareholders are receiving adequate compensation for their shares in the buyout and if the AboveNet board of directors attempted to obtain the highest possible price during negotiations with Zayo.

If you are a current shareholder of AboveNet and would like to learn more about the breach of fiduciary duty investigation by the National Securities Law Firm Gilman Law LLP, you may contact our office for a free consultation by calling (239) 221-8401 or by completing the online FREE consulation form.